SCHEMBL7708358

SCHEMBL7708358

CC1Oc2cc([N+](=O)[O-])c(Cl)cc2N=C1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
CYP3A4 P08684 1/20 0.43
AKR1B1 P15121 1/20 0.37
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
PGK1 P00558 1/20 0.35
MAPT P10636 5/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
POLB P06746 1/20 0.34
MCL1 Q07820 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
VCAM1 P19320 1/20 0.33
PDE7A Q13946 1/20 0.33
NCOA1 Q15788 1/20 0.32
NCOA3 Q9Y6Q9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7000231 0.82 TDP1 (0.36) ALDH1A1CYP3A4LMNACYP1A2CYP2C9
SCHEMBL6997153 0.82 CYP1A2 (0.34) CYP1A2CYP2C9CYP2C19MAPTMEN1
SCHEMBL6991149 0.75 NOS3 (0.48) ALDH1A1CYP3A4MAPTMEN1KMT2A
SCHEMBL7710726 0.73 ALDH1A1 (0.45) ALDH1A1CYP3A4LMNAMAPTMEN1
SCHEMBL8118541 0.71 NOS3 (0.42) ALDH1A1CYP3A4LMNAMAPTMEN1
SCHEMBL7000074 0.70 TDP1 (0.43) ALDH1A1MAPTMEN1KMT2ATSHR
SCHEMBL5670575 0.70 ESR1 (0.35)
SCHEMBL7985549 0.69 MAPT (0.43) ALDH1A1CYP3A4MAPTMEN1KMT2A
SCHEMBL7989336 0.69 MAPT (0.43) ALDH1A1CYP3A4MAPTMEN1KMT2A
SCHEMBL7000113 0.69 PARP1 (0.44) ALDH1A1CYP3A4AKR1B1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed